2020 CO*RE LEARNER ASSESSMENT (v.J) Survey

Question Title

* 6. Please select your profession:

Physician

Advanced Practice Nurse

Pharmacist

Dentist

Optometrist

Physician Assistant

Podiatrist

Other (please specify)

Question Title

* 7. I have a Registration with the DEA to prescribe controlled substances (CS)

Individual

Institutional

None

Question Title

* 8. Do you perform surgical procedures?

Yes

Question Title

* 9. Please indicate the primary area of your clinical practice:

Emergency Medicine

Family Medicine

Geriatric Medicine

Hospice/Palliative Care

Internal Medicine

Neurology

Obstetrics/Gynecology

Pain Medicine

Pediatrics

Physical Med/Rehab

Psychiatry

Substance Use Disorder

General Surgery

Orthopedic Surgery

Surgery Other

Other

Question Title

* 10. How long have you been in clinical practice?

Trainee

<5 years post training

6-10 years

11-15 years

16-20 years

Over 20 years

Question Title

* 11. Have you prescribed ER/LA opioids within the past year?

Yes

Question Title

* 12. Which comorbid condition may predict the development of chronic pain following acute pain?

A. Asthma

B. Depression

C. Diabetes Mellitus

D. Hypertension

Question Title

* 13. Pain secondary to post-herpetic neuralgia is what type of pain?

A. Mixed type

B. Neuropathic

C. Nocieptive

D. Nociplastic

Question Title

* 14. Which of the following is an anticipated outcome of a patient taking a prescribed opioid medication as recommended?

A. Diversion

B. Misuse

C. Tolerance

D. Withdrawal

Question Title

* 15. What is the first step in assessment of a patient’s pain who complains of burning and tingling in his lower extremities?

A. Complete history and physical exam to determine the cause of his pain

B. Perform social history to establish cultural background

C. Send patient for an EMG to determine possible neuropathic pain

D. Validate the patient’s provided treatment history with your state’s PDMP

Question Title

* 16. Which of the following is the most important thing to consider in creating a pain treatment plan?

A. Quality of life is not a significant factor in pain management

B. Reduction of the pain score by 25% will be the primary endpoint

C. The goal is to completely resolve pain

D. The goal is to improve functional outcomes

Question Title

* 17. According to expert guidelines, which of the following is the best sequence for establishing a pain treatment plan of care?

A. Establish the cause and type of the pain, initiate non-pharmacological and/or non-opioid therapies, regularly reassess

B. Identify the pain generator through a complete history and physical examination, initiate opioid therapy, regularly reassess

C. Obtain imaging, initiate non-pharmacological and/or non-opioid therapies, refer to pain management

D. Validate the patient’s pain complaint, obtain imaging, initiate opioid therapy, follow-up regularly

Question Title

* 18. Which side effect of opioid therapy should always prompt proactive treatment?

A. Constipation

B. Dizziness

C. Itching

D. Nausea

Question Title

* 19. In which of the following circumstances is the patient at greatest risk of life-threatening respiratory depression from opioid treatment?

A. During dosage taper

B. Upon treatment initiation

C. When converting dosage from one opioid to another

D. When co-prescribed with a benzodiazepine

Question Title

* 20. Select the correct statement regarding counseling a woman, currently on chronic opioid therapy, who is contemplating a possible pregnancy.

A. Chronic opioid therapy causes congenital skeletal abnormalities as well as bone demineralization in women

B. For pregnant women with opioid dependence, switching to methadone is safer and more successful than detoxification

C. Neonatal abstinence syndrome (NAS) is a rare adverse outcome in babies born to mothers using opioids

D. Since chronic opioid use impairs fertility, women taking opioids cannot become pregnant

Question Title

* 21. After determining that non-opioid therapies are inadequate for a patient’s pain, which of the following are the three most important things to have in place at the beginning of a trial of opioids?

A. Baseline urine drug test (UDT), psychological testing, and patient’s medication preference identified

B. Informed consent, family history, current medication reconciliation

C. Patient provider agreement (PPA), baseline urine drug test (UDT), informed consent

D. Patient provider agreement (PPA), lab work-up, social worker referral

Question Title

* 22. While all of the following behaviors might merit investigation in a patient receiving long term opioid therapy, which would most strongly prompt your concern for a possible opioid use disorder?

A. Negative urine drug test (UDT) results for the medication prescribed

B. Patient reports recent family problems and being fired from job

C. Request for a dosage increase due to lack of pain control

D. Request for an early refill

Question Title

* 23. In transitioning an 80 y/o patient from morphine 180 mg/day to oxycodone, and accounting for incomplete cross-tolerance, which one of the following would be an appropriate initial dose? Recall that thirty (30) mg of PO morphine is approximately equianalgesic to 20 mg long-acting oxycodone; that is, the equianalgesic ratio for morphine: oxycodone is 3:2 (although some tables indicate, oxycodone is roughly twice as potent as morphine).

A. Oxycodone ER 30 mg PO Q 12 hours

B. Oxycodone ER 80 mg Q 8 hours

C. Oxycodone IR 5 mg PO Q 4 hours

D. Oxycodone IR 10 mg PO Q 6 hours

Question Title

* 24. Of the following, which is an appropriate reason for tapering and discontinuing opioid medication and not a situation that calls for further investigation and increased monitoring?

A. Negative urine drug screen

B. Ongoing pain with aberrant use

C. Pain is resolving

D. Scheduled for a future surgical procedure

Question Title

* 25. What is the most important piece of information when educating patients and their families about naloxone use?

A. Be prepared to give the patient an IR dose for pain upon awakening

B. Discourage naloxone access because it promotes drug misuse

C. Secure naloxone in a home drug safe

D. Seek medical attention as soon as possible when naloxone is used

Question Title

* 1. Name of Host Institution/Organization?

Question Title

* 2. Location of CO*RE Course?

Question Title

* 3. AOA ID Number? (If you do not have or know your AOA ID, please enter None or Unknown)

Question Title

* 4. Contact Information for Attendee

Question Title

* 5. Primary State or Foreign Country of Practice:

Question Title

* 6. Please select your profession:

Question Title

* 7. I have a Registration with the DEA to prescribe controlled substances (CS)

Question Title

* 8. Do you perform surgical procedures?

Question Title

* 9. Please indicate the primary area of your clinical practice:

Question Title

* 10. How long have you been in clinical practice?

Question Title

* 11. Have you prescribed ER/LA opioids within the past year?

Question Title

* 12. Which comorbid condition may predict the development of chronic pain following acute pain?

Question Title

* 13. Pain secondary to post-herpetic neuralgia is what type of pain?

Question Title

* 14. Which of the following is an anticipated outcome of a patient taking a prescribed opioid medication as recommended?

Question Title

* 15. What is the first step in assessment of a patient’s pain who complains of burning and tingling in his lower extremities?

Question Title

* 16. Which of the following is the most important thing to consider in creating a pain treatment plan?

Question Title

* 17. According to expert guidelines, which of the following is the best sequence for establishing a pain treatment plan of care?

Question Title

* 18. Which side effect of opioid therapy should always prompt proactive treatment?

Question Title

* 19. In which of the following circumstances is the patient at greatest risk of life-threatening respiratory depression from opioid treatment?

Question Title

* 20. Select the correct statement regarding counseling a woman, currently on chronic opioid therapy, who is contemplating a possible pregnancy.

Question Title

* 21. After determining that non-opioid therapies are inadequate for a patient’s pain, which of the following are the three most important things to have in place at the beginning of a trial of opioids?

Question Title

* 22. While all of the following behaviors might merit investigation in a patient receiving long term opioid therapy, which would most strongly prompt your concern for a possible opioid use disorder?

Question Title

Question Title

* 24. Of the following, which is an appropriate reason for tapering and discontinuing opioid medication and not a situation that calls for further investigation and increased monitoring?

Question Title

* 25. What is the most important piece of information when educating patients and their families about naloxone use?

* 3. AOA ID Number?
(If you do not have or know your AOA ID, please enter None or Unknown)